Journals / Diagnostic and Interventional Radiology / 2022 / Cilt: 28 - Sayı: 1

Characteristics and efficacy of fish-derived gelatin microparticles as an embolic agent in a rabbit renal model: regulation of the degradation period by molecular weight

Pages
65–71
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Low MW GMPs degraded within 2 days with a low inflammatory response.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE We aimed to evaluate the embolic effect of fish-derived gelatin microparticles (GMPs) and compare the degradation periods and biocompatibilities of different molecular weight (MW) GMPs in a rabbit model.
📊
Key Findings & Data:METHODS GMPs were designed to degrade within 21 days (high MW GMP, 15-30 kDa) and 2 days (low MW GMP, 5-15 kDa) in vivo.
💡
Conclusion & Impact:Low MW GMPs degraded within 2 days with a low inflammatory response.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE We aimed to evaluate the embolic effect of fish-derived gelatin microparticles (GMPs) and compare the degradation periods and biocompatibilities of different molecular weight (MW) GMPs in a rabbit model. METHODS GMPs were designed to degrade within 21 days (high MW GMP, 15-30 kDa) and 2 days (low MW GMP, 5-15 kDa) in vivo. Renal arteries of 24 rabbits were embolized using both high and low MW GMPs (155-350 µm). Rabbits were sacrificed either immediately after embolization, or after follow-up angiogram on days 2 and 21 of embolization, respectively (4 rabbits in each of the 6 subgroups). Pathological changes of recanalized vessels were evaluated using the Banff classification. For the in vitro study, each type of GMP was mixed with normal saline and morphological changes were compared for 14 days. RESULTS Fish-derived GMPs showed effective embolization. On 2-day follow-up angiography, occluded vessels were more recanalized to the peripheral branches in low MW group. On day 21, parenchymal perfusion defect recovered to a greater extent in low MW group than in high MW group. Mean Banff scores for intimal arteritis on 2-day follow-up and interstitial fibrosis on 21-day follow-up were higher in high MW group (1.75 ± 0.58 vs. 0.19 ± 0.4 and 2.56 ± 0.63 vs. 0.88 ± 0.89; P < .001). On in vitro assessment, low MW GMP lost the spherical shape and degraded, and was invisible on microscopy on day 6, whereas high MW GMP was only partially degraded after 2 weeks. CONCLUSION Fish-derived GMPs showed effective embolization in a rabbit model. Low MW GMPs degraded within 2 days with a low inflammatory response.

🔖

Cite This Article

LEE, H. J., KIM, J. H., JEON, U. B., KIM, C. W., JANG, J. Y., KWON, H. (2022). Characteristics and efficacy of fish-derived gelatin microparticles as an embolic agent in a rabbit renal model: regulation of the degradation period by molecular weight. Diagnostic and Interventional Radiology, Cilt: 28 - Sayı: 1, 65–71. https://ajindex.com/articles/487216

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release. 2005
  2. 109(1-3):256-274. [Crossref] 2. Solorio L, Zwolinski C, Lund AW, Farrell MJ, Stegemann JP. Gelatin microspheres crosslinked with genipin for local delivery of growth factors. J Tissue Eng Regen Med. 2010
  3. 4(7):514-523. [Crossref] 3. van den Bosch E, Gielens C. Gelatin degradation at elevated temperature. Int J Biol Macromol. 2003
  4. 32(3-5):129-138. [Crossref] 4. Kanayama Y, Aoki C, Sakai Y. Development of low endotoxin gelatin for regenerative medicine. Biol Pharm Bull. 2007
  5. 30(2):237-241. [Crossref] 5. Medsinge A, Zajko A, Orons P, Amesur N, Santos E. A case-based approach to common embolization agents used in vascular interventional radiology. AJR Am J Roentgenol. 2014
  6. 203(4):699-708. [Crossref] 6. Alfaro AT, Balbinot E, Weber CI, Tonial IB, Machado-Lunkes A. Fish Gelatin: Characteristics, Functional Properties, Applications and Future Potentials. Food Eng Rev. 2015
  7. [Crossref] 7. Kang MG, Lee MY, Cha JM, et al. Nanogels Derived from Fish Gelatin: Application to Drug Delivery System. Mar Drugs. 2019
  8. 17(4) [Crossref] 8. Doyon D, Mouzon A, Jourde AM, Regensberg C, Frileux C. [Hepatic, arterial embolization in patients with malignant liver tumours (author's transl)]. Ann Radiol (Paris). 1974
  9. 17(6):593-603. 9. Goldstein HM, Wallace S, Anderson JH, Bree RL, Gianturco C. Transcatheter occlusion of abdominal tumors. Radiology. 1976
  10. 120(3):539- 545. [Crossref] 10. Oh JS, Lee HG, Chun HJ, Choi BG, Choi YJ. Evaluation of arterial impairment after experimental gelatin sponge embolization in a rabbit renal model. Korean J Radiol. 2015
  11. 16(1):133- 138. [Crossref] 11. Ye Y, Ren Y, Zeng H, He J, Zhong Z, Wu X. Characterization of Calibrated Gelatin Sponge Particles in a Rabbit Renal Embolization Model. Cardiovasc Intervent Radiol. 2019
  12. 42(8):1183- 1191. [Crossref] 12. Kawai N, Sato M, Minamiguchi H, et al. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles. J Vasc Interv Radiol. 2013
  13. 24(9):1383- 1390. [Crossref] 13. Lai JY, Lu PL, Chen KH, Tabata Y, Hsiue GH. Effect of charge and molecular weight on the functionality of gelatin carriers for corneal endothelial cell therapy. Biomacromolecules. 2006
  14. 7(6):1836-1844. [Crossref] 14. Lai JY. The role of bloom index of gelatin on the interaction